Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PF9X
|
|||
| Drug Name |
Bicyclo-heptan-2-amine derivative 2
|
|||
| Synonyms |
PMID28051882-Compound-20
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H31FN2
|
|||
| Canonical SMILES |
C1CCN(CC1)CCCNC2(CC3CCC2C3)C4=CC=C(C=C4)F
|
|||
| InChI |
1S/C21H31FN2/c22-20-9-7-18(8-10-20)21(16-17-5-6-19(21)15-17)23-11-4-14-24-12-2-1-3-13-24/h7-10,17,19,23H,1-6,11-16H2
|
|||
| InChIKey |
DJXNOCLZKSUJMI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
| Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.